PT  - JOURNAL ARTICLE
AU  - Trottier, Julie
AU  - Darques, Regis
AU  - Mouheb, Nassim Ait
AU  - Partiot, Emma
AU  - Bakhache, William
AU  - Deffieu, Maika S.
AU  - Gaudin, Raphael
TI  - Post-lockdown detection of SARS-CoV-2 RNA in the wastewater of Montpellier, France
AID  - 10.1101/2020.07.08.20148882
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.08.20148882
4099  - http://medrxiv.org/content/early/2020/07/09/2020.07.08.20148882.short
4100  - http://medrxiv.org/content/early/2020/07/09/2020.07.08.20148882.full
AB  - The evolution of the COVID-19 pandemic can be monitored through the detection of SARS-CoV-2 RNA in sewage. Here, we measured the amount of SARS-CoV-2 RNA at the inflow point of the main waste water treatment plant (WWTP) of Montpellier, France. We collected samples 4 days before the end of lockdown and up to 45 days post-lockdown. We detected increased amounts of SARS-CoV-2 RNA at the WWTP, which was not correlated with the number of newly diagnosed patients. Future epidemiologic investigations may explain such asynchronous finding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the CNRS. The funder had no role in the design of the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been followedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request